Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The new compound may be a safer alternative to finasteride for prostate protection.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

A Saudi individual initially identified as a girl had a genetic disorder affecting gender development.

Enzyme activities do not cause early pubic hair in these girls.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Women also use 5α-reductase inhibitors, and their effects differ from men.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

The compounds tested could potentially treat hair loss and alopecia.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.